热门资讯> 正文
展望Therapeutics股价在定价500万美元后下跌
2026-03-24 19:11
- Outlook Therapeutics (OTLK) shares fell 34% in premarket trading Tuesday after the company priced a public offering.
- The biopharma firm is selling 20M shares along with warrants to buy up to 20M shares at a combined price of $0.25. The offering is expected to raise about $5M before fees.
- The warrants are exercisable immediately at $0.25 per share and will expire in five years. The offering is expected to close around March 25, 2026, subject to standard conditions.
- Outlook Therapeutics intends to use the net proceeds from the offering primarily for working capital and general corporate purposes.
- Source: Press Release
More on Outlook Therapeutics
- Third Time's The Charm: Outlook Therapeutics' Lytenava Heads To FDA, Again
- Biggest stock movers Tuesday: CLB, OTLK, and more
- Outlook Therapeutics drops 80% on CRL for BLA for wet AMD asset
- Seeking Alpha’s Quant Rating on Outlook Therapeutics
- Historical earnings data for Outlook Therapeutics
推荐文章
美股机会日报 | 特朗普再放豪言！正与伊朗谈判，并收到伊方“大礼”；特斯拉机器人再迎新进展！马斯克称有望明年实现量产
一图看懂 | 单季盈利承压！拼多多Q4营收1239亿元同比增12%，调后净利却下跌12%；高管称“力争三年再造一个拼多多”
财报前瞻 | 美团Q4财报明日放榜！大摩、高盛逆势力挺股价，当前美团已严重超跌？
中东战火中金价狂泻11%！创43年最惨周跌，避险逻辑崩塌还是黄金坑？
美股机会日报 | 中东硝烟将散？以官员称美方4月9日结束对伊战争！海力士拟筹资百亿赴美上市，豪掷80亿美元锁定阿斯麦光刻机！
一图看懂 | 连续5个季度破千亿！小米Q4营收1169亿创历史新高；净利大增43.8%至63亿元
无论美伊谈判真假！华尔街已从特朗普引发的五分钟狂飙获得明确信号？
麦格理：紧张局势缓和后布伦特原油底部在每桶85至90美元
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
